• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS VITAMIN D TOTAL II; VITAMIN D TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS VITAMIN D TOTAL II; VITAMIN D TEST SYSTEM Back to Search Results
Catalog Number 07028148190
Device Problem High Test Results (2457)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 01/12/2021
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys vitamin d total ii results for one patient tested on a cobas 8000 e 801 module serial number (b)(4).The patient's elecsys vitamin d results were reported outside the laboratory.The patient's physician did not believe the initial result.The customer performed repeat testing with the same sample on a diasorin analyzer and an antellica analyzer.The customer also sent the patient's sample to another laboratory to be tested on an unknown analyzer with liquid chromatography with tandem mass spectrometry (lc-ms/ms) methodology.On (b)(6) 2021, the patient's elecsys vitamin d result was 84.1 ng/ml.On (b)(6) 2021, the patient's vitamin d result on a diasorin analyzer was 40 ng/ml.The patient's vitamin d result on an atellica analyzer was 54 ng/ml.The date of measurement was requested but not provided.On (b)(6) 2021, the patient's vitamin d result with lc-ms/ms methodology was 82 ng/ml.The patient's physician believed the vitamin d results from the diasorin analyzer and atellica analyzer were correct.
 
Manufacturer Narrative
The customer's qc results were acceptable.The customer's system alarm trace and sample pre-analytical details were requested but not provided.The investigation confirmed the exact specificity of the lc-ms/ms method used for testing was not provided but the lc-ms/ms result was comparable to the elecsys result obtained.Based on the available data, the investigation determined the observed discrepancy between the elecsys vitamin d total ii assay and the diasorin and antellica methods was the presence of a significant amount of a vitamin d derivate (c3-epi) in the sample.Per product labeling, the elecsys vitamin d assay does not have cross-reactivity to the vitamin d derivate (c3-epi) up to a concentration of "50 ng/ml." the investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS VITAMIN D TOTAL II
Type of Device
VITAMIN D TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key11323165
MDR Text Key255005841
Report Number1823260-2021-00456
Device Sequence Number1
Product Code MRG
Combination Product (y/n)N
PMA/PMN Number
K162840
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 04/06/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date05/31/2021
Device Catalogue Number07028148190
Device Lot Number484711
Was Device Available for Evaluation? Yes
Initial Date Manufacturer Received 01/22/2021
Initial Date FDA Received02/12/2021
Supplement Dates Manufacturer Received01/22/2021
Supplement Dates FDA Received04/06/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-